The Transplant Diagnostics Market on a global scale was estimated at USD 4.9 Bn in 2024 and is poised to attain USD 10.4 Bn by 2034, with a projected CAGR of 7.9% between 2025 and 2034.
At its core, Transplant Diagnostics pertains to The rise in organ transplants represents a considerable aspect driving demand for diagnostics utilized before surgery. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Market momentum is driven by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transplant Diagnostics Market Snapshot
Chapter 4. Global Transplant Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Molecular assay technologies
5.2.1.1. PCR-based molecular assays
5.2.1.2. Real-time PCR
5.2.1.3. Sequence-specific primer-PCR
5.2.1.4. Sequence-specific Oligonucleotide-PCR
5.2.1.5. Other PCR-based molecular assays
5.2.2. Sequencing based molecular assays
5.2.2.1. Sanger sequencing
5.2.2.2. Next generation sequencing
5.2.2.3. Other sequencing based molecular assays
5.2.3. Non molecular assays technologies
Chapter 6. Market Segmentation 2: by Product & Service Estimates & Trend Analysis
6.1. by Product & Service & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
6.2.1. Reagents & Consumables
6.2.2. Instruments
6.2.3. Software & Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Diagnostic Application
7.2.1.1. Pre-Transplantation Diagnostics
7.2.1.1.1. Infectious Disease Testing
7.2.1.1.2. Histocompatibility Testing
7.2.1.1.3. Blood Profiling
7.2.1.2. Post -Transplantation Diagnostics
7.2.2. Research Applications
Chapter 8. Market Segmentation 4: by Transplant Type Estimates & Trend Analysis
8.1. by Transplant Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Transplant Type:
8.2.1. Solid Organ Transplantation
8.2.1.1. Kidney Transplantation
8.2.1.2. Liver Transplantation
8.2.1.3. Heart Transplantation
8.2.1.4. Lung Transplantation
8.2.1.5. Pancreases Transplantation
8.2.1.6. Other Organs Transplantation
8.2.2. Stem Cell Transplantation
8.2.3. Soft Tissue Transplantation
8.2.4. Bone Marrow Transplantation
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
9.2.1. Hospitals and Transplant centers
9.2.2. Research &Academic Institutes
9.2.3. Independent reference laboratories
Chapter 10. Transplant Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.2. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
10.1.3. North America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.1.4. North America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.1.5. North America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.1.6. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.2.2. Europe Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.2.3. Europe Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.2.4. Europe Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.2.5. Europe Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.2.6. Europe Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.3.2. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.3.3. Asia-Pacific Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.3.4. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.3.5. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.3.6. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.4.2. Latin America Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.4.3. Latin America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.4.4. Latin America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.4.5. Latin America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.4.6. Latin America Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.5.2. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.5.3. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.5.4. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.5.5. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.5.6. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories, Inc.
11.2.2. Adaptive Biotechnologies
11.2.3. Affymetrix, Inc.
11.2.4. altona Diagnostics GmbH
11.2.5. Arquer Diagnostics Ltd
11.2.6. BAG Diagnostics GmbH
11.2.7. Becton, Dickinson and Company,
11.2.8. Biofortuna Limited
11.2.9. BioMerieux SA,
11.2.10. Bio-rad Laboratories, Inc.
11.2.11. Biotype GmbH
11.2.12. Bruker,
11.2.13. CareDx Inc.
11.2.14. CLONIT srl
11.2.15. Diagnóstica Longwood SL
11.2.16. DiaSorin S.p.A.
11.2.17. ELITechGroup
11.2.18. EUROFINS VIRACOR
11.2.19. F. Hoffmann La-Roche AG.
11.2.20. Hologic, Inc.
11.2.21. Horiba Ltd
11.2.22. Illumina, Inc.
11.2.23. Immucor Transplant Diagnostics, Inc.
11.2.24. Laboratory Corporation of America Holdings.
11.2.25. Linkage Biosciences
11.2.26. Luminex Corporation
11.2.27. Merck KGaA
11.2.28. NanoString
11.2.29. Olerup SSP AB
11.2.30. Omixon Ltd.
11.2.31. PathoNostics
11.2.32. Preservation Solutions, Inc.
11.2.33. Qiagen N.V.
11.2.34. Randox Laboratories Ltd.
11.2.35. Stryker
11.2.36. Takara Bio Inc.
11.2.37. Thermo Fisher Scientific,
11.2.38. TransMedics
11.2.39. Transonic
11.2.40. Zimmer Biomet
11.2.41. Other Prominent Players